We are pioneering best-in-class, targeted medicines for severe brain diseases. We don't follow crowds, chase fads, or pursue me-too drugs. We leverage non-invasive blood-brain barrier (BBB) delivery technology and mRNA engineering to design and develop life-changing medical products for patients su...See more
Headquarters:
Company Type:
SME
Company size:
1-10 Employees
Year Founded:
2024 (2 years)
Address:
MELBOURNE, AU
LOW
spending power
